首页|补中益气汤协同Siβ-catenin调控Wnt/β-catenin信号通路干预肺腺癌顺铂耐药性的分子机制研究

补中益气汤协同Siβ-catenin调控Wnt/β-catenin信号通路干预肺腺癌顺铂耐药性的分子机制研究

扫码查看
目的:探讨补中益气汤含药血清协同Siβ-catenin调控Wnt/β-catenin信号通路干预A549/DDP细胞顺铂耐药性的分子机制研究.方法:采用siRNA干扰沉默β-catenin的表达,Westernblot检测正常血清组、顺铂组、siCTNNB1-235组、siCTNNB1-510组、siCTNNB1-547组A549/DDP细胞的β-catenin蛋白的相对表达量;干扰β-catenin后,Western blot检测各组A549/DDP细胞β-catenin和Survivin的蛋白表达量,MTT法检测各组A549/DDP细胞对顺铂的IC50,Annexin V/PI染色法检测各组A549/DDP细胞顺铂诱导的凋亡率.结果:相较于正常血清组(1.00),siCTNNB1-235组(0.323±0.021)对β-catenin表达抑制率达67%(P=0.000).RNAi技术沉默β-catenin后,与正常血清组(1.00)相比,补中益气汤联合顺铂组的Survivin(0.247±0.015)和 β-catenin(0.257±0.015)蛋白的表达下调更为明显(P=0.000,P=0.000).IC50和正常血清组(28.330±1.029)μmol/L相比,单独补中益气汤含药血清(20.350±1.155)μmol/L或单独瞬时转染siCTNNB1-235组(15.577±1.535)μmol/L均可降低A549/DDP细胞顺铂的IC50(P=0.000,P=0.000),2者联合(10.453±0.999)μmol/L使用可进一步降低顺铂的IC50(P=0.000).与正常血清组(9.130±0.384)%相比,瞬时转染siCTNNB1-235联合顺铂组(64.393±0.244)%和补中益气汤联合顺铂组(70.120± 0.400)%的总凋亡率均升高(P=0.000,P=0.000).结论:补中益气汤含药血清和瞬时转染siβ-catenin在抑制Wnt/β-catenin信号通路改善肺腺癌顺铂耐药性方面具有协同效应,且补中益气汤具有siβ-catenin瞬时转染样效应.
Molecular mechanism of Buzhong Yiqi Decoction in coordination with Siβ-catenin in intervention against cisplatin resistance in lung adenocarcinoma by regulating the Wnt/β-catenin signaling pathway
Objective:To investigate the molecular mechanism of Buzhong Yiqi Decoction in coordination with Siβ-catenin in inter-vention against cisplatin resistance in A549/DDP cells by regulating the Wnt/β-catenin signaling pathway.Methods:The expression ofβ-catenin was silenced by siRNA interference,and Western blot was used to measure the relative protein expression of β-catenin in A549/DDP cells in the normal serum group,the cisplatin group,the siCTNNB1-235 group,the siCTNNB1-510 group,and the siCTNNB1-547 group.After β-catenin interference,Western blot was used to measure the protein expression levels of β-catenin and Survivin in A549/DDP cells of each group;MTT assay was used to determine the IC50 of cisplatin in A549/DDP cells of each group;Annexin V/PI staining was used to measure the cisplatin-induced apoptosis rate of A549/DDP cells in each group.Results:Compared with the normal serum group(1.00),the siCTNBN1-235 group(0.323±0.021)had an inhibition rate of 67%on β-catenin expression(P=0.000).After β-catenin was silenced by RNAi technique,compared with the normal serum group(1.00),the Buzhong Yiqi Decoc-tion+cisplatin group had significantly greater reductions in the protein expression of Survivin(0.247±0.015)and β-catenin(0.257± 0.015)(P=0.000,P=0.000).As for the IC50 of cisplatin in A549/DDP cells,compared with the normal serum group(28.330±1.029)μmol/L,serum containing Buzhong Yiqi decoction alone(20.350± 1.155)μmol/L or siCTNNB1-235 transient transfection alone(15.577±1.535)μmol/L reduced the IC50 of cisplatin in A549/DDP cells(P=0.000,P=0.000),and the combination of the two methods(10.453±0.999)μmol/L further reduced the IC50 of cisplatin(P=0.000).Compared with the normal serum group(9.130±0.384)%,the siCTNBN1-235 transient transfection+cisplatin group(64.393±0.244)%and the Buzhong Yiqi Decoction+cisplatin group(70.120±0.400)%had a significant increase in overall apoptosis rate(P=0.000,P=0.000).Conclusion:Serum containing Buzhong Yiqi Decoction and siβ-catenin transient transfection have asynergistic effect on inhibiting the Wnt/β-catenin signaling pathway and improving cisplatin resistance in lung adenocarcinoma,and Buzhong Yiqi Decoction has a siβ-catenin transient transfection-like effect.

β-cateninSurvivinRNAilung cancer drug resistanceBuzhong Yiqi Decoction

李贺、牟琪瑞、王哲、王莹、于丹、高原

展开 >

辽宁中医药大学中西医结合学院病理教研室,沈阳 110847

β-catenin Survivin RNAi 肺癌耐药 补中益气汤

辽宁省教育厅科学研究面上项目

LJKZ0901

2024

重庆医科大学学报
重庆医科大学

重庆医科大学学报

CSTPCD北大核心
影响因子:0.724
ISSN:0253-3626
年,卷(期):2024.49(2)
  • 13